Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
AstraZeneca
Baylor College of Medicine
University of Nebraska
VM Oncology, LLC
Cancer Research UK
LigaChem Biosciences, Inc.
University of Colorado, Denver
Jonsson Comprehensive Cancer Center